Patents by Inventor Vincent J. Ferrari
Vincent J. Ferrari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6595951Abstract: The present invention is directed to a closure system for an oral active agent delivery device. The device comprises an elongate tubular member having first and second ends. The closure system includes a deformable closure means adapted to allow delivery of the active agent upon deformation. The closure system prevents spillage and maintains the integrity of the dose within the device. In use, the closure system is deformed and separated from the second end of the tubular member, liquid is drawn up into the first end of the member, and the liquid and active agent are drawn out of the second end of the member and into the patient's mouth.Type: GrantFiled: May 19, 2000Date of Patent: July 22, 2003Assignee: Alza CorporationInventors: Patrick S. -L. Wong, James Horvath, Radomir N. M. Vukadin, Joyce C. Anthony, Vincent J. Ferrari, Jeffrey W. Etter, Christopher M. G. Ohms
-
Patent number: 6572582Abstract: The present invention is directed to a mixing system for an active agent delivery device. The device comprises an elongate tubular member having first and second ends and a mixing system. The mixing system enables the entire dose of active agent to be entrained in a liquid. In use, liquid is drawn into the first end of the device, the mixing system mixes the liquid and active agent within the device and the active agent entrained in the liquid is drawn out of the second end of the member and into the patient's mouth.Type: GrantFiled: November 23, 1999Date of Patent: June 3, 2003Assignee: Alza CorporationInventors: Patrick S. L. Wong, Stephen S. Hwang, Vincent J. Ferrari
-
Patent number: 6235111Abstract: A phosphatizing system for phosphatizing an object including a closed-loop phosphatizing assembly is provided configured to pass a phosphatizing reagent solution over an object during a phosphatizing procedure. The phosphatizing assembly includes a collection compartment in fluid communication with a run-off portion of a subfloor assembly supporting the object for receipt of substantially all the reagent run-off fluids from the subfloor assembly. A storage assembly is configured to pass a rinsing solution over the object to wash the reagent solution therefrom during a finishing rinse procedure performed after the phosphatizing procedure. This storage assembly includes a storage compartment in fluid communication with the run-off portion for receipt of substantially all the rinsing/reagent run-off fluids from the subfloor assembly.Type: GrantFiled: November 25, 1998Date of Patent: May 22, 2001Assignee: EZ Environmental Solutions, CorporationInventors: Scott A. Comiso, Vincent J. Ferrari, Neil J. Bailer, Michael D. Damron, Nhan Nguyen Thanh Lam
-
Patent number: 6224908Abstract: Oral active agent delivery system having improved flow controllers. A hollow tubular member containing the active agent formulation and having a fluid passing controller is placed at one end into a fluid and at a second end into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.Type: GrantFiled: May 24, 2000Date of Patent: May 1, 2001Assignee: Alza CorporationInventors: Patrick S.-L. Wong, Vincent J. Ferrari, Jeffrey W. Etter, Miriam A. Martin, Nathan Roth, Christopher M. G. Ohms, Andrew I. Poutiatine, James Horvath
-
Patent number: 6183466Abstract: A dosage form is disclosed comprising a wall that defines an injection-molded compartment housing a capsule comprising a drug formulation.Type: GrantFiled: June 25, 1999Date of Patent: February 6, 2001Assignee: Alza CorporationInventors: Patrick S. L. Wong, Felix Theeuwes, Vincent J. Ferrari, Liang C. Dong
-
Patent number: 6153678Abstract: Polymeric compositions are disclosed comprising a poly(caprolactone), a poly(alkylene oxide), a poly(oxyethylenated fatty acid ester), or a poly(oxyethylenated fatty acid), or a poly(oxyethylene-co-oxypropylene).Type: GrantFiled: October 6, 1998Date of Patent: November 28, 2000Assignee: Alza CorporationInventors: Liang-Chang Dong, Crystal Pollock, Patrick S.-L. Wong, Keru O. Shafi, Vincent J. Ferrari, Ted Smith
-
Patent number: 6103265Abstract: The present invention is directed to an oral active agent delivery system comprising improved flow controllers. A hollow tubular member (10) containing the active agent formulation and having a fluid passing controller (14) is placed at one end (16) into a fluid and at a second end (18) into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.Type: GrantFiled: September 22, 1999Date of Patent: August 15, 2000Assignee: ALZA CorporationInventors: Patrick S.-L. Wong, Vincent J. Ferrari, Jeffrey W. Etter, Miriam A. Martin, Nathan Roth, Christopher M. G. Ohms, Andrew I. Poutiatine, James Horvath
-
Patent number: 6096003Abstract: The present invention is directed to a closure system for an oral active agent delivery device. The device comprises an elongate tubular member having first and second ends. The closure system includes a deformable closure means adapted to allow delivery of the active agent upon deformation. The closure system prevents spillage and maintains the integrity of the dose within the device. In use, the closure system is deformed and separated from the second end of the tubular member, liquid is drawn up into the first end of the member, and the liquid and active agent are drawn out of the second end of the member and into the patient's mouth.Type: GrantFiled: October 14, 1997Date of Patent: August 1, 2000Assignee: ALZA CorporationInventors: Patrick S.-L. Wong, James Horvath, Radomir N. M. Vukadin, Joyce C. Anthony, Vincent J. Ferrari, Jeffrey W. Etter, Christopher M. G. Ohms
-
Patent number: 6024721Abstract: The present invention is directed to a mixing system for an active agent delivery device. The device comprises an elongate tubular member having first and second ends and a mixing system. The mixing system enables the entire dose of active agent to be entrained in a liquid. In use, liquid is drawn into the first end of the device, the mixing system mixes the liquid and active agent within the device and the active agent entrained in the liquid is drawn out of the second end of the member and into the patient's mouth.Type: GrantFiled: October 15, 1997Date of Patent: February 15, 2000Assignee: ALZA CorporationInventors: Patrick S.-L. Wong, Stephen S. Hwang, Vincent J. Ferrari
-
Patent number: 5985324Abstract: The present invention is directed to an oral active agent delivery system comprising improved flow controllers. A hollow tubular member (10) containing the active agent formulation and having a fluid passing controller (14) is placed at one end (16) into a fluid and at a second end (18) into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.Type: GrantFiled: May 7, 1998Date of Patent: November 16, 1999Assignee: ALZA CorporationInventors: Patrick S.-L. Wong, Vincent J. Ferrari, Jeffrey W. Etter, Miriam A. Martin, Nathan Roth, Christopher M. G. Ohms, Andrew I. Poutiatine, James Horvath
-
Patent number: 5910321Abstract: The present invention is directed to an oral active agent delivery system and method for delivering discrete units of an active agent to a patient. An elongate tubular member having first and second ends comprises first and second flow paths. Either or both of said flow paths contains an active agent. Liquid is drawn up into the first end of the member, and the liquid and active agent is drawn out of the second end of the member and into the patient's mouth.Type: GrantFiled: October 14, 1997Date of Patent: June 8, 1999Assignee: Alza CorporationInventors: Patrick S.-L. Wong, Nathan Roth, Vincent J. Ferrari
-
Patent number: 5830502Abstract: A dosage form is disclosed comprising an injection-molded housing member free of organic solvents.Type: GrantFiled: November 5, 1996Date of Patent: November 3, 1998Assignee: ALZA CorporationInventors: Liang C. Dong, Patrick S. L. Wong, Crystal Pollock, Vincent J. Ferrari
-
Patent number: 5817335Abstract: The present invention is directed to a fluid-imbibing drug delivery device which is useful for the initial delayed delivery of an active agent formulation to a fluid environment of use, the initial delay period to startup or activation being of a predetermined length of time. The dispensing device is formed of a first and second housing that are in reversibly sliding telescoping arrangement with each other. The first housing contains the active agent formulation and has an aspect ratio less than 1. The housings are preferably. ovoloid in shape.Type: GrantFiled: May 26, 1995Date of Patent: October 6, 1998Assignee: ALZA CorporationInventors: Patrick S.-L. Wong, Liang C. Dong, Vincent J. Ferrari, Jeri D. Wright, Steven D. Larsen
-
Patent number: 5614578Abstract: A dosage form is disclosed comprising an injection-molded housing member free of organic solvents.Type: GrantFiled: October 28, 1994Date of Patent: March 25, 1997Assignee: Alza CorporationInventors: Liang C. Dong, Patrick S. L. Wong, Crystal Pollock, Vincent J. Ferrari
-
Patent number: 5534263Abstract: The present invention is directed to an active agent dosage form which is useful for the prolonged delivery of an active agent formulation to a fluid environment of use. The active agent dosage form is a matrix that has on its surface two or more insoluble bands. The invention is also directed to the method for making the active agent dosage form.Type: GrantFiled: February 24, 1995Date of Patent: July 9, 1996Assignee: Alza CorporationInventors: Patrick S.-L. Wong, David E. Edgren, Liang C. Dong, Vincent J. Ferrari